ICD-10-CM Code for Duloxetine
There is no specific ICD-10-CM code for duloxetine itself—ICD-10-CM codes classify diagnoses and conditions, not medications. You need to code the underlying condition being treated with duloxetine.
Understanding the Coding System
ICD-10-CM is a diagnostic classification system used to code diseases, symptoms, and clinical findings—not medications 1. When documenting duloxetine use, you must assign the appropriate diagnosis code for the condition being treated.
Common Diagnosis Codes for Duloxetine Indications
Based on FDA-approved indications and clinical guidelines 2, 3, 4, here are the relevant ICD-10-CM codes for conditions treated with duloxetine:
Neuropathic Pain Conditions
- E11.42 - Type 2 diabetes with diabetic polyneuropathy (painful diabetic peripheral neuropathy) 5
- E10.42 - Type 1 diabetes with diabetic polyneuropathy
- G89.29 - Other chronic pain (for general neuropathic pain)
Musculoskeletal Pain
- M25.5XX - Pain in joint (for osteoarthritis pain) 4
- M54.5 - Low back pain (chronic) 4
- M79.7 - Fibromyalgia 4
Psychiatric Conditions
- F32.X - Major depressive disorder, single episode (various severity codes)
- F33.X - Major depressive disorder, recurrent
- F41.1 - Generalized anxiety disorder 6
Other Conditions
- R10.84 - Generalized abdominal pain (for stress urinary incontinence context)
Clinical Documentation Requirements
Document the specific diagnosis being treated, not just "patient on duloxetine." The diagnosis code must reflect:
- The primary condition requiring treatment
- Severity when applicable (mild, moderate, severe)
- Laterality for joint conditions
- Episode type for depression (single vs. recurrent)
Common Pitfall
The most frequent error is attempting to code the medication rather than the diagnosis. ICD-10-CM codes identify what condition the patient has, while the medication (duloxetine) is documented separately in the medication list or procedure codes if applicable 1.
For billing and documentation purposes, always use the diagnosis code that corresponds to the FDA-approved indication or evidence-based off-label use for which you are prescribing duloxetine 3, 4, 2.